PHARMATHENE, INC for PHARMATHENE, INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 17, 2011 | $299,325 | Replaced |
| 3rd Quarter - Amendment | Jan 26, 2012 | $224,325 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
House and Senate Reauthorization of Pandemic and All Hazards preparedness Act (PAHPA; H.R. 2402), FY-2012 Appropriations Continuing Resolution (H.R. 2608), FY-2012 Labor-HHS Approporiations, Increased funding for BARDA at HHS, Medical Countermeasures (MCMs) for biodefense thrwats, specifically 2nd Generation anthrax rPA Vaccine and anthrax antitoxin
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANCESCA COOK | Sr. VP Policy and Government Affairs |
| MARK EDWARD COOKE | Sr. Director Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.